Editorial Note: BioNTech mRNA. RSI 48.1, up slightly from 45.9 on 06/16. Price ticked up +2.2% to $91.49 (from $89.50), but the trend label has shifted from "weak-down" to "strong-down" with a death cross now flagged (golden cross false) — a mixed read where near-term price firmed slightly while the moving-average structure deteriorated further (SMA20 $92.04 -0.6%, SMA50 $92.22 -0.8%, SMA200 $99.00 -7.6%). 7D is -3.52% (a pullback from the recent bounce), 30D +2.18% (similar to the prior +0.73%), 3M -5.39% (essentially flat vs -5.65%). From 52wk high, -26.22% (modest improvement from -27.82%). Thesis unchanged; still no directional confirmation — the death-cross flag is a new data point worth tracking but the underlying price action remains rangebound.

2026-07-17 tape note: Essentially unchanged. BNTX $91.48 (flat vs $91.49), RSI 48 (flat), trend label now reads "weak-up." 7D -0.01%, 30D +0.65%, 3M -13.03% (softer as the trailing window rolls). -26.23% from 52wk high, essentially flat. Death cross still flagged. Thesis unchanged; still rangebound with no directional confirmation. No new fundamentals re-researched.

2026-07-25 tape note (Friday 2026-07-24 close): Rangebound has tilted lower. BNTX $89.33 (-2.4% from $91.48), RSI 40.9 (down from 48.0), trend label back to "strong-down" (from "weak-up") — price is now below SMA20 (-3.4%), below SMA50 (-2.0%, flipped from +0.1% above), and further below SMA200 (-9.3%, vs -7.4%). Death cross still flagged. 7D -2.35% (from -0.01%), 30D -0.98% (flipped negative from +0.65%), 3M -15.29% (deepened from -13.03%). -25.76% from 52wk high, essentially flat vs -26.23%. Thesis unchanged; still no directional confirmation but this cycle's tape has softened rather than firmed. No new fundamentals re-researched.

2026-07-28 tape note: The tilt lower has reversed. BNTX $92.45 (+3.5% from $89.33), RSI 51.2 (up from 40.9), trend label back to "weak-up" (from "strong-down") — price has reclaimed SMA50 (+1.4%, from -2.0% below) and is essentially back at SMA20 (-0.2%, from -3.4% below), though still below SMA200 (-6.1%, improved from -9.3%). Death cross still flagged (structural). 7D +0.13% (flipped positive from -2.35%), 30D -1.92% (roughly flat vs -0.98%), 3M -8.98% (improved from -15.29%). -25.44% from 52wk high, essentially flat vs -25.76%. Thesis unchanged; still rangebound, this cycle firmed rather than softened. No new fundamentals re-researched. Per the full-scan summaries (2026-07-28 close). 2026-07-31 tape note: BNTX $90.58 (-2.02% vs $92.45), RSI 45.5 (cooled from 51.2). 7D +1.40% (accelerated from +0.13%), 30D -3.56% (deepened from -1.92%), 3M -7.14% (moderated from -8.98%). From the 52-week high, the gap is -26.95% (widened from -25.44%). Per the tape: trend "strong-down", regime "pullback", no golden cross. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: BNTX $93.67 (+3.41% vs $90.58), RSI 55.4 (warmed from 45.5). 7D +3.41% (accelerated from +1.40%), 30D +0.15% (turned positive from -3.56%), 3M -0.48% (moderated from -7.14%). From the 52-week high, the gap is -25.66% (narrowed from -26.95%). Per the tape: trend "weak-up", regime "basing", death cross confirmed. No new fundamentals re-researched. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: BNTX $93.09 (-0.62% vs $93.67), RSI 53.8 (cooled from 55.4). 7D -0.62% (turned negative from +3.41%), 30D +1.20% (accelerated from +0.15%), 3M +3.95% (turned positive from -0.48%). From the 52-week high, the gap is -25.71% (essentially flat from -25.66%). Per the tape: trend "weak-up", regime "basing", death cross confirmed. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).

Price Data

---

Research Log

Sources

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-31 tape — insider-universe.
• Prior-cycle history: this file's dated update log (refreshed each full scan).